Detailed View
KRYS - Krystal Biotech, Inc.
Latest filing: 2026-06-30 | Reporting: gaap
Market Cap
9,606,301,696
Adj EBIT (TTM)
280,832,959.40
Enterprise Value
8,760,670,696
Last Price
324.55
Earnings Yield
3.21%
Return on Capital
20.45%
Capital
1,373,251,000
1Y Price Chart
Last Price: $324.55
1Y Change: 71.13%
As of 2026-10-29 | 1Y Change: 71.13%
Company Summary
Loading summary...
| endDate | formType | fiscalYear | Revenue | OperatingIncomeLoss |
|---|---|---|---|---|
| 2026-06-30 | 10-Q | 2026 | 119,222,000 | 58,418,000 |
| 2026-03-31 | 10-Q | 2026 | 116,357,000 | 53,689,000 |
| 2025-12-31 | 10-K (Q4 derived) | 2025 | 107,105,000 | 44,270,000 |
| 2025-09-30 | 10-Q | 2025 | 97,800,000 | 41,542,000 |
| 2025-06-30 | 10-Q | 2025 | 96,042,000 | 39,306,000 |
| 2025-03-31 | 10-Q | 2025 | 88,183,000 | 36,177,000 |
| 2024-12-31 | 10-K (Q4 derived) | 2024 | 91,140,000 | 41,380,000 |
| 2024-09-30 | 10-Q | 2024 | 83,841,000 | 22,433,000 |
Notice something wrong?
Submit a quick report with a snapshot of the values you are seeing.